Duranti, S., Inno, A., Rossi, V., Turazza, M., Fiorio, E., Fabi, A., et al. (2015). Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study. In 17th National Congress of Medical Oncology (pp.13-13). Elsevier BV.

Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study

Zambelli A;
2015

abstract
Oncology
English
17th National Congress of Medical Oncology - OCT 23-25, 2015
2015
17th National Congress of Medical Oncology
2015
26
S6
13
13
A32
none
Duranti, S., Inno, A., Rossi, V., Turazza, M., Fiorio, E., Fabi, A., et al. (2015). Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study. In 17th National Congress of Medical Oncology (pp.13-13). Elsevier BV.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/560565
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact